Skip to content
Disclosery

EXANE DERIVATIVES: MTZ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MTZ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,557 MTZ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,557 shares
    Change vs previous 13F -695 shares

    0.11% of the 13F portfolio, value $183,197.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,252 shares
    Change vs previous 13F -584 shares

    0.08% of the 13F portfolio, value $283,232.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,836 shares
    Change vs previous 13F -61 shares

    0.09% of the 13F portfolio, value $353,973.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,897 shares
    Change vs previous 13F -3,240 shares

    0.08% of the 13F portfolio, value $336,221.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,137 shares
    Change vs previous 13F +5,980 shares

    0.17% of the 13F portfolio, value $740,304.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,157 shares
    Change vs previous 13F +224 shares

    0.03% of the 13F portfolio, value $108,406.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 933 shares
    Change vs previous 13F +375 shares

    0.02% of the 13F portfolio, value $63,609.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 558 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $23,546.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).